#AUROPHARMA | 👔 Aurobindo Pharma has approved its Q2 and H1 financial results for the period ending September 30, 2024. Standalone revenue: INR 28,245.9M, profit before tax: INR 7,237.5M. Consolidated revenue: INR 77,960.7M, profit before tax: INR 12,074.6M. 

Details:⚡ AI powered update byCheck-outto receive WhatsApp updates faster than twitter/X.